SCHEMBL7083313

SCHEMBL7083313

O=CCc1cccc(Cc2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.52
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
IDH1 O75874 1/20 0.45
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
HNF4A P41235 1/20 0.43
MPO P05164 1/20 0.42
ACMSD Q8TDX5 1/20 0.41
MAOB P27338 2/20 0.41
MAOA P21397 1/20 0.41
ELANE P08246 1/20 0.40
PLA2G10 O15496 1/20 0.39
PLA2G2A P14555 1/20 0.39
LMNA P02545 1/20 0.39
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH7 P40394 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12345478 0.86 MAOB (0.39) MAOBMAOALMNAADH1BADH1C
SCHEMBL26987979 0.84 MAOB (0.44) CALM1PRSS1PRSS2PRSS3IDH1
SCHEMBL7613502 0.83 CALM1 (0.75) CALM1PRSS1PRSS2PRSS3IDH1
SCHEMBL13971231 0.83 CALM1 (0.75) CALM1PRSS1PRSS2PRSS3IDH1
SCHEMBL13377220 0.83 MAOB (0.52) MAOBMAOA
SCHEMBL13680785 0.82 MTNR1A (0.47) CALM1PRSS1PRSS2PRSS3IDH1
SCHEMBL7011745 0.80 TSHR (0.46) CALM1PRSS1PRSS2PRSS3IDH1
SCHEMBL9319525 0.80 CALM1 (0.55) CALM1PRSS1PRSS2PRSS3IDH1
SCHEMBL5780715 0.79 BCHE (0.51) MAOALMNAADH1BADH1CADH1A
SCHEMBL417837 0.78 MAOA (0.58) CALM1PRSS1PRSS2PRSS3IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed
EP-1196384-A4 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO INC (US) 2002-10-23 EP disclosed
EP-1196384-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF Merck & Co., Inc. (US) 2002-04-17 EP disclosed
WO-2001000578-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO., INC. (US) 2001-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 CALM1 2116/4885PRSS1 129/4885PRSS2 1052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.